C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/28 (2006.01) A61K 39/39 (2006.01) A61K 39/395 (2006.01) C07K 7/04 (2006.01) C07K 14/725 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2116526
2116526 9304695 PCTABS00020 There is provided by this invention a novel method of treating rheumatoid arthritis in a mammal. The method comprises the steps of obtaining a sample of synovium from the mammal; identifying in said sample T cell receptor variable regions; and administering to said mammal an effective amount of antibodies to at least one of said T cell receptor variable regions or antigenic fragments thereof. The invention further provides a novel method of treating rheumatoid arthritis in a mammal comprising the steps of administering to said mammal an effective amount of antibodies to mammalian T cell receptor variable regions selected from the group consisting of V.alpha.17, V.alpha.1, V.beta.12, V.beta.14, V.beta.17 and V.beta.7 and antigenic fragments thereof. The invention further comprises a novel method for immunizing a mammal to prevent the occurrence of rheumatoid arthritis or to treat ongoing rheumatoid arthritis. The method comprises the steps of administering to said mammal mammalian T cell receptor variable regions selected from the group consisting of V.alpha.17, V.alpha.1, V.beta.12, V.beta.14, V.beta.17, V.beta.7 and antigenic fragments thereof. Kits comprising mammalian T cell receptor variable regions selected from the group consisting of V.alpha.17, V.alpha.1, V.beta.12, V.beta.14, V.beta.17 and V.beta.7 and antigenic fragments thereof or antibodies to said variable regions are also provided by the invention.
Weiner David B.
Williams William V.
Smart & Biggar
The Trustees Of The University Of Pennsylvania
The Wistar Institute
LandOfFree
T cell receptor-based therapy for rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with T cell receptor-based therapy for rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and T cell receptor-based therapy for rheumatoid arthritis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1978114